| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $109.90B | — | +21.8% |
| Cost of Revenue | $41.27B | — | +13.5% |
| R&D Expense | $17.03B | — | +25.6% |
| SG&A Expense | $4.29B | — | +21.2% |
| Operating Income | $39.70B | — | +29.7% |
| Pre-tax Income | $77.41B | — | +85.2% |
| Income Tax | $14.83B | — | +104.6% |
| Net Income | $62.58B | — | +81.2% |
| EPS (Basic) | $5.17 | — | +82.0% |
| EPS (Diluted) | $5.11 | — | +81.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $38.06B | +24.0% | +63.6% |
| Short-term Investments | $88.78B | -7.7% | +23.2% |
| Accounts Receivable | $63.00B | +0.2% | +23.5% |
| Current Assets | $213.75B | +3.7% | +31.9% |
| Total Assets | $703.92B | +18.2% | +48.1% |
| Current Liabilities | $111.19B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $45.79B | — | +26.7% |
| Capital Expenditures | $35.67B | — | +107.4% |
| Investing Cash Flow | -$63.39B | — | -291.4% |
| Financing Cash Flow | $25.08B | — | +224.1% |
| Free Cash Flow | $10.12B | — | -46.6% |
| +21.3% |
| Long-term Debt | $77.50B | +57.9% | +611.9% |
| Total Liabilities | $225.17B | +25.1% | +73.1% |
| Stockholders' Equity | $478.75B | +15.3% | +38.7% |